The Regulatory Blitz: How Federal Antitrust and CMS Overhauls Are Dismantling Healthcare's Legacy Monopolies
Federal agencies have initiated a coordinated regulatory blitz, dismantling legacy healthcare monopolies through CMS Med...
Read More →Government policies, insurance, and healthcare systems.
Federal agencies have initiated a coordinated regulatory blitz, dismantling legacy healthcare monopolies through CMS Med...
Read More →A comprehensive analysis of the 2026 healthcare policy landscape, examining the downstream effects of PBM reform, Medica...
Read More →The simultaneous implementation of CMS Medicare Advantage risk recalibration, FDA AI liability shifts, and PBM spread-pr...
Read More →The simultaneous implementation of the IRA $2,000 out-of-pocket cap, the DOJ's PBM antitrust probe, and the GLP-1 employ...
Read More →The convergence of AI-verified biometric reimbursement, the FTC's dismantling of PBM-insurer vertical monopolies, and fe...
Read More →October 2026 marks the definitive collapse of the Medicare Advantage arbitrage model as CMS slashes risk-adjustment rate...
Read More →The simultaneous CMS Medicare Advantage risk overhaul, the FTC/DOJ PBM probe, the 340B expansion, the site-neutral payme...
Read More →CMS and the FTC have launched a coordinated regulatory offensive against PBM rebate retention and Private Equity physici...
Read More →The convergence of CMS risk-adjustment recalibration, HHS transparency penalties, and AI diagnostic mandates is fundamen...
Read More →The convergence of Medicare Part D risk-shifting, state-level PBM warfare, and aggressive CMS physician reimbursement cu...
Read More →